Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
The Cost-Effectiveness of Bosentan in the United Kingdom for Patients with Pulmonary Arterial Hypertension of WHO Functional Class III
Value in Health, 06/26/09
Stevenson M et al. - Bosentan is likely to be a more cost-effective first-line therapy for patients with PAH FC III in the UK than no active intervention.
Related Articles
Economic evaluation of arthritis self management in primary care
British Medical Journal, 10/08/09
Relevance Score: 87%
Extended prophylaxis of venous thromboembolism with fondaparinux in patients undergoing major orthopaedic surgery in Italy: a cost-effectiveness analysis
Internal and Emergency Medicine, 11/10/09
Relevance Score: 84%
Public health impact and cost effectiveness of mass vaccination with live attenuated human rotavirus vaccine (RIX4414) in India: model based analysis
British Medical Journal, 10/08/09
Relevance Score: 84%
Economic Evaluation and Cost-Effectiveness Thresholds: Signals to Firms and Implications for R&D Investment and Innovation
PharmacoEconomics, 10/07/09
Relevance Score: 84%
Fine-needle aspiration of primary osseous lesions: A cost effectiveness study
Diagnostic Cytopathology, 10/06/09
Relevance Score: 84%
Today in Economics of Medicine...keeping you current
Receive free subspecialty "5-minute updates" via email
Cash flow squeeze: 2012 IRS rule will withhold some Medicare pay
American Medical News , 12/11/09
Medicaid would cover 15 million more people under health reform bills
American Medical News , 12/10/09
House passes major Medicare payment reform; what will the Senate do
American Medical News , 12/09/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


